Literature DB >> 23225803

The change of prostate cancer treatment in Korea: 5 year analysis of a single institution.

Dong Hoon Lee1, Ha Bum Jung, Mun Su Chung, Seung Hwan Lee, Byung Ha Chung.   

Abstract

PURPOSE: We analyzed changes to the trends of prostate cancer management and patient characteristics at a single institute during 5 years due to the significant increase of the prostate cancer incidence and the robotic equipment in Korea.
MATERIALS AND METHODS: Prostate cancer patient data from a single institute recorded from 2006 to 2010 were analyzed. Cancer stage, initial treatment modalities, and the pattern of outpatient clinical management were reviewed.
RESULTS: Between 2006 and 2010, 386 prostate cancers were newly diagnosed at the institute. The proportion of localized and locally advanced cancer cases increased from 67% in 2006 to 79% in 2010 respectively. Among the treatment choices during follow-up in the out-patients clinic, the proportion of radical prostatectomies increased from 43% in 2006 to 62% in 2010. In contrast, the proportion of hormone therapies decreased from 58% to 37%. For initial treatment choice, radical prostatectomy was chosen for 59% of the patients who were newly diagnosed with cancer during the study period. However, hormone therapy alone was administrated as a primary therapy to 26%. Analysis of the radical prostatectomy subgroup showed that a robot- assisted technique was used in 83% of the patients, and the remaining 17% underwent an open radical prostatectomy.
CONCLUSION: As the prostate cancer incidence increased in Korea, the proportion of localized and locally advanced cancer also increased. In addition, the main treatment modality changed from non-surgical treatment to radical prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23225803      PMCID: PMC3521261          DOI: 10.3349/ymj.2013.54.1.87

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  14 in total

1.  Global cancer statistics.

Authors:  D M Parkin; P Pisani; J Ferlay
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

2.  Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry.

Authors:  Gerard P McVey; Sean McPhail; Sarah Fowler; Gregor McIntosh; David Gillatt; Chris C Parker
Journal:  BJU Int       Date:  2010-10       Impact factor: 5.588

Review 3.  Trends in primary androgen depletion therapy for patients with localized and locally advanced prostate cancer: Japanese perspective.

Authors:  Hideyuki Akaza
Journal:  Cancer Sci       Date:  2006-04       Impact factor: 6.716

Review 4.  Changing demography of prostate cancer in Asia.

Authors:  Hong Gee Sim; Christopher W S Cheng
Journal:  Eur J Cancer       Date:  2005-04       Impact factor: 9.162

Review 5.  The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE.

Authors:  Hideyuki Akaza; Shiro Hinotsu; Michiyuki Usami; Osamu Ogawa; Susumu Kagawa; Tadaichi Kitamura; Taiji Tsukamoto; Seiji Naito; Yoshihiko Hirao; Masaru Murai; Hidetoshi Yamanaka; Mikio Namiki
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

Review 6.  The current status of robot-assisted radical prostatectomy.

Authors:  Prokar Dasgupta; Roger S Kirby
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

7.  Rising prostate cancer rates in South Korea.

Authors:  Sue Kyung Park; Lori C Sakoda; Daehee Kang; Anand P Chokkalingam; Eunsik Lee; Hai-Rim Shin; Yoon-Ok Ahn; Myung-Hee Shin; Choong-Won Lee; Duk-Hee Lee; Aaron Blair; Susan S Devesa; Ann W Hsing
Journal:  Prostate       Date:  2006-09-01       Impact factor: 4.104

8.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

9.  Characteristics of patients with prostate cancer who have initially been treated by hormone therapy in Japan: J-CaP surveillance.

Authors:  Hideyuki Akaza; Michiyuki Usami; Shiro Hinotsu; Osamu Ogawa; Susumu Kagawa; Tadaichi Kitamura; Taiji Tsukamoto; Seiji Naito; Yoshihiko Hirao; Masaru Murai; Hidetoshi Yamanaka
Journal:  Jpn J Clin Oncol       Date:  2004-06       Impact factor: 3.019

10.  Current status of endocrine therapy for prostate cancer in Japan analysis of primary androgen deprivation therapy on the basis of data collected by J-CaP.

Authors:  Shiro Hinotsu; Hideyuki Akaza; Michiyuki Usami; Osamu Ogawa; Susumu Kagawa; Tadaichi Kitamura; Taiji Tsukamoto; Seiji Naito; Mikio Namiki; Yoshihiko Hirao; Masaru Murai; Hidetoshi Yamanaka
Journal:  Jpn J Clin Oncol       Date:  2007-10-26       Impact factor: 3.019

View more
  13 in total

1.  Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes.

Authors:  Yeon-Joo Kim; Kwan Ho Cho; Hong Ryull Pyo; Kang Hyun Lee; Sung Ho Moon; Tae Hyun Kim; Kyung Hwan Shin; Joo-Young Kim; Young-kyung Kim; Se Byeong Lee
Journal:  Strahlenther Onkol       Date:  2014-10-23       Impact factor: 3.621

2.  Can Western based online prostate cancer risk calculators be used to predict prostate cancer after prostate biopsy for the Korean population?

Authors:  Dong Hoon Lee; Ha Bum Jung; Jae Won Park; Kyu Hyun Kim; Jongchan Kim; Seung Hwan Lee; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

3.  Epidemiology of prostate cancer in South Korea.

Authors:  Hyun Ho Han; Jae Won Park; Joon Chae Na; Byung Ha Chung; Choung-Soo Kim; Woo Jin Ko
Journal:  Prostate Int       Date:  2015-07-17

4.  Seventh Joint Meeting of K-J-CaP and CaPSURE: extending the global initiative to improve prostate cancer management.

Authors:  Hideyuki Akaza; Choung Soo Kim; Peter Carroll; In Young Choi; Byung Ha Chung; Matthew R Cooperberg; Yoshihiko Hirao; Shiro Hinotsu; Shigeo Horie; Ji Youl Lee; Mikio Namiki; Chi-Fai Ng; Mizuki Onozawa; Seiichiro Ozono; Satoru Ueno; Rainy Umbas; Dingwei Ye; Gang Zhu
Journal:  Prostate Int       Date:  2014-06-30

5.  Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer.

Authors:  Choung Soo Kim; Young Deuk Choi; Sang Eun Lee; Hyun Moo Lee; Takeshi Ueda; Junji Yonese; Takashi Fukagai; Edmund Chiong; Weber Lau; Sarang Abhyankar; Ad Theeuwes; Bertrand Tombal; Tomasz M Beer; Go Kimura
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.

Authors:  Do Kyung Kim; Kyo Chul Koo; Kwang Suk Lee; Yoon Soo Hah; Koon Ho Rha; Sung Joon Hong; Byung Ha Chung
Journal:  J Korean Med Sci       Date:  2018-10-16       Impact factor: 2.153

7.  Simultaneous robot-assisted laparoendoscopic single-site partial nephrectomy and standard radical prostatectomy.

Authors:  Jae Hung Jung; Hong Wook Kim; Cheol Kyu Oh; Jae Mann Song; Byung Ha Chung; Sung Joon Hong; Koon Ho Rha
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

8.  Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.

Authors:  Seung-Hwan Lee; Hyun-Moo Lee; Sae-Woong Kim; Eun-Sik Lee; Sung-Joon Hong; Choung-Soo Kim; Taek-Won Kang; Byung-Ha Chung
Journal:  Yonsei Med J       Date:  2014-03       Impact factor: 2.759

9.  The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients.

Authors:  Choung-Soo Kim; Ad Theeuwes; Dong Deuk Kwon; Young Deuk Choi; Byung Ha Chung; Hyun Moo Lee; Kang Hyun Lee; Sang Eun Lee
Journal:  Investig Clin Urol       Date:  2016-05-10

10.  Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center.

Authors:  Ji Eun Heo; Hyun Kyu Ahn; Jinu Kim; Byung Ha Chung; Kwang Suk Lee
Journal:  J Korean Med Sci       Date:  2018-02-05       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.